BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 1286 | Download: 1081
 |
Received |
|
2013-03-05 10:03 |
 |
Peer-Review Started |
|
2013-03-05 15:16 |
 |
To Make the First Decision |
|
2013-04-16 09:09 |
 |
Return for Revision |
|
2013-04-18 16:25 |
 |
Revised |
|
2013-05-21 06:53 |
 |
Second Decision |
|
2013-07-11 08:21 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-07-11 13:04 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-09-07 14:20 |
 |
Publish the Manuscript Online |
|
2013-09-21 09:08 |
Category |
Surgery |
Manuscript Type |
Review |
Article Title |
Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases
|
Manuscript Source |
Invited Manuscript |
All Author List |
Bassam Abu-Wasel, Caolan Walsh, Valerie Keough and Michele Molinari |
Funding Agency and Grant Number |
|
Corresponding Author |
Michele Molinari, MD, MSc, Associate Professor, Department of Surgery and Community Health and Epidemiology, Dalhousie University, Room 6-302 Victoria Building, 1276 South Park Street, Halifax, Nova Scotia B3H 2Y9, Canada. michele.molinari@cdha.nshealth.ca
|
Key Words |
Polycystic liver disease; Hepatic; Epidemiolgy; Classification; Therapy; Genetic |
Core Tip |
The management of patients with symptomatic polycystic liver disease is challenging. Among several treatments options, the most common interventions are: percutaneous cyst aspiration, fenestration, hepatic resection and liver transplantation. There is no consensus on the best treatment options and the optimal timing for interventions in symptomatic patients. In vision of these limitations, we reviewed the most recent literature and present a comprehensive article on this topic. |
Publish Date |
2013-09-21 09:08 |
Citation |
Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol 2013; 19(35): 5775-5786 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i35/5775.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i35.5775 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345